SANDOZ CLONAZEPAM
SANDOZ CLONAZEPAM
Discontinued
DIN Number
02233960
Drug Class
Human
Market Date
Dec 2, 1997
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02233960
AIG Number0111558001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N03AE01 CLONAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
CLONAZEPAMActive
Strength: 0.5 MG
Monograph: CLONAZEPAM